The ROC curve indicated that SLC2A1 had high accuracy in predicting the outcomes of normal and tumor (Figure 2E), and the area under the ROC curve was 0.901 (95% CI: 0.869–0.934). The gene discussed is SLC2A1; the disease is neoplasm.